Some of Incyte’s biopharmaceutical drugs can help skin problems and one seems to be a cure for vitiligo, CEO Hervé Hoppenot said in an update Thursday. He also said the company plans to renovate the two downtown MBNA buildings in a way that will make them unrecognizable to the people familiar with how they look now. And he predicted that …
Delaware biopharmaceutical company Incyte was named the winner of the Pete du Pont Freedom Foundation’s 2024 Freedom Award. The award, named for the former Delaware governor, who died in 2021, at the age of 86. The award is given annually to an individual or organization that has championed a successful idea that has led to economic growth and brought innovation …
Incyte will buy two former MBNA buildings in downtown Wilmington, Bracebridge I and Bracebridge III, which will allow the biopharmaceutical company to move about 850 jobs into the city, expand its laboratory space in Alapocas, and move 300 jobs into Delaware. The 517,307 square feet in the Bracebridge buildings will almost double the company’s Delaware footprint. Incyte will focus first …
A night to celebrate all things business and jobs started Monday with a call for Delaware to ready itself to become a manufacturing hub. China long has been a magnet for manufacturing, but its decision to limit couples to one child soon will mean there’s not a big enough workforce to man factories, said Mike Quaranta, president of the Delaware …
